Related Experiment Video
Updated: May 10, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Development of a Lateral Flow Assay for the Detection of the Hepatitis C Virus Core Antigen
Erick Joan Vidal-Alcántara1, Sonia Hernández Antón2, Paloma Rueda2
1Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.
Insights
A new lateral flow assay detects hepatitis C core antigen (HCVcAg), offering a rapid and cost-effective screening tool. This assay enhances accessibility for hepatitis C virus (HCV) testing, particularly in resource-limited settings.
Area of Science:
- Virology
- Immunology
- Biotechnology
Background:
- Hepatitis C virus (HCV) infection is a significant global health concern.
- Current diagnostic methods for HCV are complex, expensive, and have limited accessibility.
Purpose of the Study:
- To develop a lateral flow immunochromatography assay for detecting hepatitis C core antigen (HCVcAg).
- To create a rapid, cost-effective, and user-friendly diagnostic tool for HCV screening.
Main Methods:
- Utilized a double antibody sandwich format with four specific monoclonal antibodies.
- Evaluated latex and colloidal gold as detector nanoparticles.
- Tested recombinant HCVcAg from five genotypes and assessed matrix effects in serum samples.
Main Results:
- Identified optimal antibody pairs through evaluation of 32 combinations.
- Developed the LN17 assay with a target sensitivity of 10 ng/strip.
- Gained insights into matrix effects for improved clinical application.
Conclusions:
- The developed assay shows potential for rapid and cost-effective HCV screening.
- The assay can improve accessibility to hepatitis C testing in high-risk populations and resource-limited areas.
Background:
Hepatitis C virus (HCV) infection remains a global health challenge, with millions of people affected annually. Current diagnostic methods, reliant on antibody screening and viral RNA detection, are complex, costly, and often inaccessible, particularly in resource-limited settings.
Aim:
Development of a lateral flow immunochromatography-based assay for detecting the highly conserved hepatitis C core antigen (HCVcAg).
Methods:
The assay relies on the interaction of four highly specific and cross-reactive monoclonal antibodies with recombinant HCVcAg from five different genotypes in a double antibody sandwich format. Latex and colloidal gold were evaluated as detector nanoparticles.
Results:
Extensive evaluation of 32 antibody combinations led to identifying the most sensitive antibody pairs. The chosen assay, named LN17, demonstrated a target sensitivity of 10 ng/strip, with potential clinical implications for detecting HCV. Furthermore, the study examined matrix effects in serum samples, providing valuable insights for future clinical application.
Conclusions:
The developed assay holds promise as a rapid, cost-effective, and user-friendly tool to enhance accessibility to hepatitis C screening, especially in high-risk populations and resource-limited environments.
More Related Videos
10:10Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds
Published on: November 13, 2021
07:13Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
Published on: June 28, 2024
Related Concept Videos
Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Hepatitis